Introduction: Percutaneous nephrolithotomy (PCNL) is the recommended first-line treatment for staghorn stones. To achieve complete stone clearance, PCNL may require using multiple tracts. Objective: To evaluate outcome of PCNL in patients with staghorn calculi and its correlation with the number of tracts and stone features. Materials and Methods: One hundred consecutive patients with staghorn renal stone who underwent PCNL were included in the study. Perioperative and postoperative features were recorded. Correlation of the variables with number of tracts and stone size was assessed. Results: Mean age (±SD) was 49.6 ± 14.7 years. Our patients were ASA class I. The mean cumulative stone burden was 365.9 ± 156.5 mm2. The mean number of tracts was 2.4 (range: 1–7), and stone-free rate was 83%. The stone-free rate (p = 0.026) and hospital stay (p = 0.005) correlated with stone size, but not with number of tracts. Postoperative fever correlated with stone size (p = 0.017) and number of tracts (p = 0.037). Conclusion: PCNL using multiple tracts seem to be effective and safe in treatment of staghorn calculi. Most outcome measures correlated with stone size rather than number of tracts.

Keywords:
Single tract, Multiple tracts, Staghorn renal stones, Percutaneous nephrolithotomy
1.
Ganpule AP, Desai M: Management of the staghorn calculus: multiple-tract versus single-tract percutaneous nephrolithotomy. Curr Opin Urol 2008;18:220–223.
2.
Lingeman JE, Matlaga BR, Evan AP: Surgical management of upper urinary tract calculi; in Wein AJ, Kavoussi LR (eds): Campbell-Walsh Urology, ed 9. Philadelphia, Saunders Elsevier, 2007, pp 1431–1507.
3.
Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS Jr, AUA Nephrolithiasis Guideline Panel: Chapter 1: AUA Guideline on Management of Staghorn Calculi: diagnosis and treatment recommendations. J Urol 2005;173:1991–2000.
4.
Singla M, Srivastava A, Kapoor R, Gupta N, Ansari MS, Dubey D, et al: Aggressive approach to staghorn calculi – safety and efficacy of multiple tracts percutaneous nephrolithotomy. Urology 2008;71:1039–1042.
5.
Stoller ML, Wolf JS, St Lezin MA: Estimated blood loss and transfusion rates associated with percutaneous nephrolithotomy. J Urol 1994;152:1977–1981.
6.
Martin X, Tajra LC, Gelet A, Dawahra M, Konan PG, Dubernard JM: Complete staghorn stones: percutaneous approach using one or multiple percutaneous accesses. J Endourol 1999;13:367–368.
7.
Kukreja R, Desai M, Patel S, Bapat S, Desai M: Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol 2004;18:715–722.
8.
Desai MR, Kukreja RA, Patel SH, Bapat SD: Percutaneous nephrolithotomy for complex pediatric renal calculus disease. J Endourol 2004;18:23–27.
9.
Netto NR Jr, Ikonomids J, Ikari O, Claro JA: Comparative study of percutaneous access for staghorn calculi. Urology 2005;65:659–663.
10.
Muslumanoglu AY, Tefekli A, Karadag MA, Tok A, Sari E, Berberoglu Y: Impact of percutaneous access point number and location on complication and success rates in percutaneous nephrolithotomy. Urol Int 2006;77:340–346.
11.
Turna B, Nazli O, Demiryoguran S, Mammadov R, Cal C: Percutaneous nephrolithotomy: variables that influence hemorrhage. Urology 2007;69:603–607.
12.
Aron M, Yadav R, Goel R, Kolla SB, Gautam G, Hemal AK, et al: Multi-tract percutaneous nephrolithotomy for large complete staghorn calculi. Urol Int 2005;75:327–332.
13.
Wong C, Leveillee RJ: Single upper-pole percutaneous access for treatment of > or = 5-cm complex branched staghorn calculi: is shockwave lithotripsy necessary? J Endourol 2002;16:477–481.
14.
Undre S, Olsen S, Mustafa N, Patel A: ‘Pass the ball!’ Simultaneous flexible nephroscopy and retrograde intrarenal surgery for large residual upper-pole staghorn stone. J Endourol 2004;18:844–847.
15.
Grasso M, Lang G, Taylor FC: Flexible ureteroscopically assisted percutaneous renal access. Tech Urol 1995;1:39–43.
16.
Ganpule AP, Mishra S, Desai MR: Multiperc versus single perc with flexible instrumentation for staghorn calculi. J Endourol 2009;23:1675–1678.
17.
Zhong W, Zeng G, Wu W, Chen W, Wu K: Minimally invasive percutaneous nephrolithotomy with multiple mini tracts in a single session in treating staghorn calculi. Urol Res 2011;39:117–122.
18.
Hegarty NJ, Desai MM: Percutaneous nephrolithotomy requiring multiple tracts: comparison of morbidity with single-tract procedures. J Endourol 2006;20:753–760.
19.
Akman T, Sari E, Binbay M, Yuruk E, Tepeler A, Kaba M, et al: Comparison of outcomes after percutaneous nephrolithotomy of staghorn calculi in those with single and multiple accesses. J Endourol 2010;24:955–960.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.